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Introduction: Emergency treatment of major sub-/total traumatic amputations continue to represent a clinical
challenge due to high infection rates and serious handicaps. Effective treatment is based on two columns: surgery and
antimicrobial therapy. Detailed identification of pathogen spectrum and epidemiology associated with these injuries is
of tremendous importance as it guides the initial empiric antibiotic regimen and prevents adverse septic effents.
Methods: In this retrospective study 51 patients with major traumatic amputations (n = 16) and subtotal amputations
(n = 35) treated from 2001 to 2010 in our trauma center were investigated. All patients received emergency surgery,
debridement with microbiological testing within 6 h after admission and empircic antimicrobial therapy. Additionally
to baseline patient characteristics, the incidence of positive standardized microbiologic testing combined with clinical
signs of infection, pathogen spectrum, administered antimicrobial agents and clinical complications were analyzed.
Results: 70.6% of the patients (n = 36) acquired wound infection. In 39% wounds were contaminated on day 1,
whereas the mean length of duration until first pathogen detection was 9.1 ± 13.4 days after injury. In 37%
polymicrobial colonization and 28% Pseudomonas were responsible for wound infections during hospitalization.
In 45% the empirc antimicrobial therapy focussed on Gram positive strains did not cover the detected bacteria,
according antimicrobial resistogram. It was significantly more often found in infections associated with Pseudomonas
(p 0.02) or polymicrobial wound infections.
Conclusions: This epidemiologic study reveals a pathogen shift from Gram-positive to Gram-negative strains with high
incidence of Pseudomonas and polymicrobial infections in sub-/total major traumatic amputations. Therefore, empiric
antimicrobial treatment historically focussing on Gram-positive strains must be adjusted. We recommend the use of
Piperacillin/Tazobactam for these injuries. As soon as possible antimicrobial treatment should be changed from empiric
to goal directed therapy according to the microbiological tests and resistogram results.
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The emergency treatment of subtotal and total traumatic
amputations (type IIIC open fractures according to the
Gustilo/Anderson and type IV according to Tscherne/
Oestern classification) with extensive soft tissue injury
represents a clinical challenge [1-3]. Although sub-/total
traumatic amputations are rare injuries, the potential
risk for individual detrimental consequences are serious,
including limb loss, infections, osteomyelitis, delayed or
non-union, bone segmental defects, soft tissue defects
and sensomotor deficits, which in turn cause major
socioeconomic costs [4-7].
The successful management of open fractures and trau-
matic amputations is limited due to high infection rate
(<50%), poor soft tissue coverage, impaired fracture
healing, non-union and secondary amputation. Traumatic
amputations are known to be almost always contaminated
with any sort of pathogen, predominately Gram-positive
strains [8]. The infection rates are associated with the
severity of soft tissue damage (muscle injury, wound
contamination, blood supply, reperfusion injury), applica-
tion of tourniquet in the field and need of fasciotomy
in compartment syndrome [1,2,6,9-12]. In particular,
sub-/total traumatic amputations with ischemia are
more susceptible to infections. Moreover, following
vascular repair and reperfusion, severe reperfusion
edema and post-ischemic compartment syndrome are
observed. Reperfusion syndrome additionally impairs
the restored microcirculatory perfusion and local delivery
of antibiotics due to endothelial leakage and pre-capillary
shunting. Furthermore, traumatic coagulopathy and coagu-
lation factor deficiency (e.g. factor XIII) are known to
additionally impair wound healing and predispose towards
wound infection [13].
The two cornerstones for successful sub-/total
traumatic amputation treatment are emergency surgery
with bleeding control, radical debridement, temporary
stabilization and early, sufficient empiric antimicrobial
therapy [7,14]. Despite high infection rates up to 66%,
the most effective type or combination of empiric
antimicrobial agent in open fractures and traumatic
amputations are still a controversy [2,6,15-18]. In the
last decades Staphylococcus aureus, Staphylococcus
epidermidis and Gram-negative strains have been the
predominate pathogens in these injuries [8]. Empiric
antimicrobial therapy is focusing on epidemiologic data,
plausible pathogens and patient’s specific comorbidities
(e.g. allergy, diabetes). But current epidemiologic data for
sub-/total traumatic amputations are not available and
microbiological spectrum and corresponding bacterial
resistances are changing over the time.
Therefore, this study aimed to retrospectively analyze
the characteristics, epidemiologic microbiological patho-
gen spectrum, incidence of multi-resistant pathogens, theefficiency of antimicrobial therapy, the incidence of
multiple trauma and coagulopathy of all sub-/total
traumatic amputations, treated in our center.
Methods
In this retrospective study we included 51 sub-/total
traumatic amputations treated at the Campus Virchow
Klinikum, Charité - Universitätsmedizin between 2001
and 2010. Due to the retrospective and observational
character of the study no approval by our local ethic
committee has been necessary.
Inclusion criteria
 Major sub-/total traumatic amputation (type IV
Gustilo/Anderson Anderson and Tscherne/Oestern;
n = 16) [2,3]
 Severe open fractures with vascular injury and large
soft tissue injury (>5 cm defect or more than loss of
3/4 of circumference; type IIIC Gustilo/Anderson
and type IV Tscherne/Oestern; n = 35) [2,3].
Exclusion criteria
 Type IIIc open fractures with <5 cm soft tissue
defect or <3/4 of circumference [2]
 Minor traumatic amputations (finger, toe)
 Survival <24 hours or patients dying before
obtaining microbiological test
 Lack of substantial information in medical record.
The baseline characteristics (gender, age, trauma
mechanism, injury type, anatomical fracture location
(AO classification) and following parameters were
recorded:
 Abbreviated Injury Scale (AIS) and Injury Severity
Score (ISS)
 Hanover Polytrauma Score (PTS)
 Clinical signs of wound infection (rubor, calor, dolor,
wound secretion)
 Microbiological testing (swab, tissue, wound
secretion)
 Pathogen type (Gram positive/negative)
 Laboratory findings (white blood count (WBC),
C-reactive protein (CRP))
 Type and sufficiency of antimicobial therapy
 Risk factors for infection (diabetes, immune
deficiency, compartment syndrome, arterial
occlusive disease, nicotine/alcohol abuse)
 Length of hospital stay and critical care
 Type and number of surgical procedures, revisions
and use of negative pressure wound therapy
(NPWT/VAC)
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osteosynthesis materials due to infection, secondary
amputation).
The leading injury was defined as the body region
(head, face/neck, thorax, abdomen, extremities) with the
highest AIS score. Polytrauma was classified according
to ISS >15 and severe polytrauma ISS >25.
Traumatic coagulopathy on admission, negatively
influencing wound healing, microcirculation and the
clinical course of open fractures, was defined by INR >1.2
and/or platelet count <100 000/nl [13,19].
Microbiological assessment and definition of wound
infections
All microbiological tests of the 51 patients were screened
for pathogen type, number of simultaneous pathogens,
resistance towards administered antimicrobial agent and
time until positive pathogen proof.
Microbiological specimens (i.e. wound swabs, tissue
samples, drain fluids) were obtained during surgery
before debridement and administration of antibiotic
therapy. Within operation at least 2 wound swabs
(superficial and deep) were obtained. Based on sur-
geon’s decision additionally tissue samples were obtain
under sterile conditions. Drains were standardized re-
moved within 2 days after surgery except high
amount of wound secretion. Therefore, drain fluids
were tested in case of persisting secretion >48 hours
after surgery. Initial surgical debridement was performed
within 2 hours after injury, followed by staged surgical de-
bridement until conditioning of soft tissue or plastic sur-
gery, depending on the clinical situation. Specimens
were sent native (i.e. without transport media) and
cultivated within 6 hours of sampling, except patient
arrived at night, then samples were cultivated next
morning. Samples were plated on sheep blood agar
plates and incubated for 7 days under aerobic and
anaerobic conditions at 37°C; an aliquot was in addition
inoculated in thioglycolate broth. Identification and
susceptibility testing of grown microorganisms were
performed as standard microbiological methods. Wound
cultures on day 1 refer to intraoperative microbiological
samples collected before the first surgical debridement
and antibiotic therapy, reflecting the incidence and
spectrum of initial wound contamination.
Wound infection was defined as the proof of at
least one pathogenic species in microbiological testing
combined with clinical signs of infection (fever, pus, rubor,
odor, macerated soft tissue) and elevated laboratory
infectious parameter (WBC, CRP). A wound infection
occurring within 14 days after trauma was defined as an
early infection. Simultaneous detection of more than one
pathogen species in the same sample was classified aspolymicrobial wound infection. The initially applied
antibiotic therapy was considered to be insufficient, if
proven so by the microbiological resistance determination
via antibiogram.
Surgical management
Our algorithm for limb salvage and surgical decision
making was published in 2010 and performed with
the help of the Mangled Extremity Severity Score ≥7,
injury severity (polytrauma: “life before limb”) and physio-
logic parameters (base deficit, lactate, blood pressure,
and coagulopathy [6,20].
Out of 42 cases (82%) of limb salvage, revascularization
was successfully performed in 37 cases (73%). In 18%
primary (n = 9), 14% (n = 7) macro-replantation and
10% (n = 5) secondary amputation was performed.
Our soft tissue management is guided by the degree of
open fracture, contusions, contamination and defect size.
According to secondary swelling with progressive soft
tissue necrosis and compartment syndrome primary
wound closure in type III open fractures was an excep-
tion. In our protocol we performed open amputations in
case of primary amputation. Criteria for stump forma-
tion were clean wean, no pathogen proof obtained in
the microbiological test in the prior operation and
no need for surgical debridement. We covered the soft
tissue defects in type III open fractures with Epigard® +
dry dressing in 44 patients, 5 open wound treatment
with initial dry dressing and 1 primary NPWT. In 1
case primary wound closure was possible. The dress-
ings were changed at least once every day. NPWT
was used in 25 patients (49%) and were changed be-
tween 2–5 days according to wound conditions while sur-
gery and results of microbiological testing.
Multiple trauma patients were treated according to
their injury severity and hemodynamic constitution with
life before limb principle for in extremis patients and
damage control orthopedic surgery for hemodynamic
unstable patients.
Statistic
Statistical analysis was conducted by use of PASW
statistics 21.0 (IBM, USA; Mann–Whitney-/ Wilcoxon
test). Continuous variables were described with standard




51 patients were included in this study (male/female:
n = 42/9; 82/18%, mean age: 37.5 ± 13.4 years, 62.7% coagu-
lopathy at admission, 7.8% mortality rate). The length of
hospitalization in non-survivors (mean 39 ± 42.4 days; range
16–103 days) compared to survivors (mean 39.5 ± 20.4 days;
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Therefore, non-survivors were not excluded from analysis.
The mean injury severity was 24.7 ± 13.0 points for ISS
and 34.8 ± 20.7 points for PTS. 62% were polytraumatized
(n = 31, ISS > 15 points) and 52.9% suffered a severe poly-
trauma (n = 27, ISS >25 points). The trauma mechanisms
are shown in Table 1.
In polytraumatized patients the most common injury
according to the AIS was extremity trauma (n = 39;
76.5%), followed by chest trauma (n = 9; 17.6%) and
abdomen trauma (n = 3; 5.9%). The anatomic location
of the open fractures are shown in Figure 1.Risk factors for infection
Risk factors for wound infection were negligible
(Table 2). We found no significant difference for the rate
of wound infections in patient’s with-/out risk factors
or/and compartment syndrome.Injuries
68.6% of the patients sustained subtotal (n = 35) and
31.4% total traumatic amputation (n = 16). No statistical
significant differences was found for subtotal and
total traumatic amputation referring injury severity,
hospitalization (39.1 ± 22.4, range 7–103 days), ICU-days
(11.9 ± 14.2, range 0–78 days), survival, acute (OF:51%/
n = 18; amputation: 69%/n = 11) and total infection
rate (OF:66%/n = 23; amputation: 81%/n = 13), type of
infection, number and type of needed surgical interven-
tions. Also no differences for the above listed parameters
were detected for limb salvage (72.6%; n = 37), primary
(17.6%; n = 9) and secondary amputation (9.8%; n = 5). But
the mean ISS showed a trend to primary (27.9 ± 12.5
points) and secondary amputation (28.8 ± 15.1 points)
compared to limb salvage group (23.3 ± 13 points). Severe
polytrauma (ISS > 25) was more frequent in primary (67%)
and secondary amputation (60%) compared to limb
salvage group (49%).
The number of surgical interventions was 4.4 ± 3.6 for
limb salvage, 4.3 ± 3.2 for primary amputation and 9.2 ± 4.4
for secondary amputations. We observed a higher num-
ber operations in the secondary compared to the pri-
mary amputation and limb salvage group (p 0.04).Table 1 Trauma mechanism in sub-/total traumatic amputatio
Trauma me
Injury pattern Fall Pedestrian
vs. train
Motor-cyclist
Type IIIC open fracture 11 6 5
Amputation 1 6 5
Total 12 12 10
Distribution of injury pattern according to underlying trauma mechanism in type IIIThe analysis of common laboratory testing (CRP, leuco-
cyte count) revealed no association with the incidence and
type of infection.
The traumatic coagulopathy was significantly associated
with higher injury severity (PTS p 0.003, ISS p 0.008),
severe polytrauma (p 0.02), increased number of surgical
revisions (p 0.003) and most relevant, significantly higher
infection rate (p 0.03).
In 47.1% (n = 24) late complications occurred (45.8%
osteomyelitis, 25% early implant removal due to infection,
29.2% secondary amputation).
Microbiological findings
In total more than two thirds of the patients (70.6%,
n = 36) acquired a wound infections during their
hospitalization. The rate of polymicrobial wound infec-
tions and Pseudomonas infections in all patients (n = 51)
during hospitalization were 37.3% (n = 19) and 27.5%
(n = 14), respectively. 14 out of 36 patients with wound
infections had a positive Pseudomonas wound swab
(38.9%) during hospitalization, in which 50%/n = 7 were
detected within 72 hours after admission. The distribution
of 14 pseudomonas species have been: 9 P. aeruginosa, 2
P. putida and 1 P. oryzihabitans, P.fluorescens and
Aeromonas hydrphilia, respectively.
First pathogen proof
In 38.9% (n = 14) the first microbiologic test, obtained
under sterile conditions within 2 hours after trauma, was
positive, indicating that nearly 40% are admitted with
contaminated wounds. In contrast, the first positive
pathogen proof within several surgical debridement was
detected in mean 9.1 ± 13.4 days (range 1–61 days) after
injury. Epidemiologic analyses of all pathogen revealed
polymicrobial infections (25.5%/n = 13) and Pseudomonas
(23.5%/n = 12) as the most frequently detected pathogen
in the first positive microbiological testing. Polymicrobial
infections assembled in 51.9% from gram-negative and
positive strains, 25.9% more than one gram-negative strain
and 7.4% more than one gram-positive strain.
Early infections
In 56.9% (n = 29) patients fulfilled the criteria of an early
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C open fractures (subtotal amputations) and total traumatic amputations.
Figure 1 Anatomic location of sub-/total traumatic
amputations. The lower leg was the predominate injured body
region followed by the upper extremity.
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(n = 12) were detected in the first positive microbiologic
test within 14 days.
An overview of the epidemiology of pathogens in open
fractures and amputations during hospitalization is
shown in Table 3 and the temporal distribution of positive




Immune deficiency 0 0
Arterial occlusive disease 1 2
Smoker 3 5.9
Alcohol abuse 1 2
Compartment syndrome 8 15.7
Risk factors in 51 patients with type IIIC open fractures (subtotal-) and
traumatic amputations to acquire infection.Patients with acute Pseudomonas wound infections
within 14 days after trauma (n = 13, NPWT 85%, p 0.01)
and Pseudomonas wound infections while hospitalization
(n = 14, NPWT 79%, p 0.03) were significantly more often
treated with negative pressure wound therapy (NPWT)
compared to no acute (n = 38, NPWT 37%) or no
Pseudomonas wound infection (n = 37, NPWT 38%).
We observed no methicillin-resistant Staphylococcus
aureus (MRSA) but 13.7% (n = 7) carbapenem-resistant
Gram-negative strains. The carbapenem-resistant Gram-
negative pathogens were detected at mean 17 ± 10 days
(Range 3-31days) after injury.
Neither the incidence of early wound infection nor the
fact of completed sufficient initial antibiotic therapy did
show a significant effect on the length of critical care
treatment and hospitalization period. Also the number
of revision surgeries conducted to reach wound closure,
soft tissue coverage and skeletal reconstruction did also
not significantly differ in patients with early wound
infections compared to patients without wound infection.
Furthermore, no relation was found between the injury
severity and infection rate. Additionally, the injury severity
according to ISS and PTS had no significant impact on
the incidence of a Pseudomonas or polymicrobial wound
infection. We found also no statistical significant
differences referring the infection rate, acute infection,
Pseudomonas infection, combined infections and appro-
priate antimicrobial treatment in polytrauma (ISS > 15
points) and severe polytrauma (ISS >25 points) compared
to non polytraumatized patients.Antimicrobial therapy
All 51 patients received empiric antibiotic therapy after
admission. The most common antibiotic agents and
frequency of application are shown in Table 4.
Initial antimicrobial mono-therapy (aminopenicillin
plus a beta-lactamase inhibitor) was performed in 66.7%
(n = 33) while 29.4% (n = 15) received a double antibiotic
therapy. In 45.1% the empiric antibiotic therapy was
insufficient according to the later reported microbiological
findings and antibiogram. Additionally, the insufficient
antibiotic therapy according antibiogram was signifi-
cantly associated with an increase of Pseudomonas wound
infection (<14 days p 0.05; during hospitalization p 0.02).Discussion
Open fractures and major traumatic amputations are
typically observed among high-energy velocity victims.
Appropriate therapeutic management of these severe
and rare injuries, including radical debridement, micro-
surgical revascularization and replantation belongs to
the most advanced techniques in orthopedic surgery and
requires enormous experience.
Table 3 Epidemiology of pathogens in sub-/total traumatic amputation
1st wound culture Acute infection (<14d) Total
Pathogen n n n
Bacteria
Aerobic
Gram-positive Staphylococcus aureus 4 2 7
Bacillus cereus 6 5 6
Enterococcus faecalis 2 2 5
Staphylococcus epidermidis 2 2 4
Enterococcus faecium 3 1 3
Staphylococcus saprophyticus 1 1 1
Staphylococcus capitis 0 1 1
Streptococcus spp. 1 1 1
Rothia mucilaginosa 1 1 1
Lactobacillus spp. 1 1 1
Gram-negative Pseudomonas spp. 12 13 14
E.coli 3 3 5
Enterobacter spp. 2 2 5
Acinetobacter spp. 3 3 3
Pantoea agglomerans 3 3 3
Stenotrophomonas spp. 0 1 2
Acromobacter spp. 0 1 2
Klebsiella spp. 0 1 1
Proteus spp. 0 0 1
Chryseomonas luteola 1 1 1
Acromonas hydrophila 1 1 1
Anaerobic
Bacteroides fragiles 1 1 1
Fusobacterium spp. 1 1 1
Anaerococcus prevotei 1 1 1
Clostridium spp. 0 1 1
Fungi
Candida spp. 1 0 3
Aspergillus spp. 1 1 2
Paecilomyces ilacinus 0 0 1
Seedosporium spp. 0 0 1
Mucor spp. 1 1 1
Fusarium spp. 1 1 1
Combined pathogens 13 12 19
(>1 species simultaneously)
Pathogen spectrum of 51 patients with type IIIC open fractures (subtotal-) and traumatic amputations; spp = species. Highest incidence of Pseudomonas spp. and
combined pathogens (bolt letters).
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The predominantly injured body region in our collective
was the lower leg, which confirms the findings of various
other studies [5,18,21-27]. Notably, most of the studies
exclusively investigated open fractures (type I-III) of thelower leg, whereas our study includes all major traumatic
amputations and only type IIIC open fracture within the
study period [9,11,28-31]. More than half of the patients
included in our study were severely polytraumatized
(ISS >25 points). We could not find a significant relation
Figure 2 Temporal incidence of positive polymicrobial and
Pseudomonas pathogen proof. Temporal distribution of positive
polymicrobial and Pseudomonas pathogen proof in sub-/total
traumatic amputations; y-axis: days after trauma; x-axis: admission:
Specimen obtain within emergency surgery; early infect: positive
pathogen proof within 14 days after trauma; total: incidence of
positive pathogen proof within hospitalization period.
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study, confirming previously published data for battlefield
injuries [12]. We postulate that the individual posttraumatic
immune response predispose for infection due to immune
depression or pro-inflammatory reactions, not measurable
by an anatomical injury severity score [32]. We definitely
suggest a specific subgroup of polytrauma patients to
be susceptible to acquire infection. Therefore, we
need immunological tools to detect and characterize
posttraumatic immune response and allocate an individual
risk guiding decision-making in polytrauma [32]. In
contrast, traumatic coagulopathy was significantly as-
sociated with higher infection rate and higher injury se-
verity. Our data suggest that traumatic coagulopathy
predisposes for wound infections underscoring the recent
detected cross talk of complement system and coagulation
factors [33]. We found no statistically significant differ-
ences for wound infections in subtotal traumatic amputa-
tion and primary major traumatic amputations. It is
conceivable, that at this high level of severe soft tissue
damage with ischemia in both injury types the alreadyTable 4 Antimicrobial therapy
Antibiotic agent n %
Ampicillin/Sulbactam 25 49.0
Ampicillin/Sulbactam + Clindamycin 5 9.8
Amoxycillin/Clavulanic acid 4 7.8
Cefuroxime 3 5.9
Cefuroxime + Clindamycin 2 3.9
Ceftriaxone + Clindamycin 2 3.9
Ciprofloxacin + Clindamycin 2 3.9
Clindamycin 2 3.9
Empiric antimicrobial therapy and frequency of application.high risk of wound infection does not further increase.
Comparison with previous publications is critical, because
most studies include all types of open fractures and no
traumatic amputation injuries [34-36].
Microbiology
Due to exclusively type IIIc open fracture the rate of
wound infections (70.6%) in our study exceeds the infection
rates of previously published data (5-40%) supporting the
fact, that the infection rate is strongly related to the extend
of the soft tissue injury and vascularization [2,6,15,16,37].
The epidemiologic part of this study revealed a shift from
Gram-positive to Gram-negative pathogens in subtotal and
total traumatic amputation compared to literature [1,8].
We observed a high rate of Pseudomonas and polymicro-
bial wound infections already at admission to the hospital
within emergency operation less then 2 hours after trauma
and within hospitalization. This fact indicates the change
of natural pathogen environment. Especially Pseudomonas
was considered as a late hospitalization infection [12]. We
detect a unique high Pseudomonas infection rate of 39%
compared to the literature [8,11,34]. Furthermore, in our
clinical experience we observe more and more primary
Gram-negative contaminations or infections also in
type II/IIIa/IIIb open fractures. For us, there is a clear
trend towards Gram-negative strains in open fractures.
The use of NPWT is a controversy with positive and
negative effects [31,38-40]. In our study we found a
significant association between Pseudomonas wound
infection and treatment with NPWT. A study revealed the
NPWT foam as a hatchery for especially Pseudomonas.
Therefore, NPWT has also disadvantages and should not
be abused to delay or substitute plastic surgery in trau-
matic amputations [41]. Temporary soft tissue coverage
with artificial skin coverage (Epigard®) or dry dressings
can induce moistening and maceration of the wound. The
humid wound atmosphere, fluid collections, bradytrophic
tissue in an environment of Gram-positive focused
empiric antimicrobial therapy might lead to a survival
advantage and secondary selection of Gram-negative path-
ogens. Additionally the abuse of antimicrobial therapy
combined with NPWT has the potential to select multire-
sistant pathogens, e.g. the carbapenem-resistant Gram-
negative strains in our study. All multiple resistances were
detected after hospitalization and under antimicrobial
therapy at mean 10 days after trauma.
In contrast, the initial temporary vacuum-assisted
wound coverage followed by early wound closure or
plastic surgery has the potential to lower the secondary
infection rates with Gram-negative rods, especially
Pseudomonas, because of droughty effects on the wound
side and removal of fluid collections predisposed for
bacterial secondary colonization with hospitality pathogens
in the future.
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The change of pathogen spectrum to Gram-negative
strains has tremendous impact on the choice of empiric
antimicrobial therapy and morbidity of our patients.
Former empiric therapy focused on the reported epidemio-
logic data from 1990s with predominate Gram-positive
strains. Therefore, we detect in 45% of our patients the em-
piric antibiotic regimen as insufficient and were signifi-
cantly associated with Pseudomonas or polymicrobial
wound infections. The data of this study clearly indicate
the need to adjust the empiric antimicrobial therapy for
type IIIc open fractures and traumatic amputations. How-
ever, remarkable controversy exists about the use of anti-
biotic therapy and guidelines similar to e.g. the 2013
WSES guidelines for intra-abdominal infections are
absent [42,43].
Successful treatment of open fractures and traumatic
amputations has two cornerstones, sufficient empiric
antimicrobial therapy in combination with immediate
radical surgical debridement [1,6,10,15,18,31]. We recom-
mend the use of empiric antimicrobial therapy in sub-/total
traumatic amputations with Piperacillin/Tazobactam (4.5 g
i.v. 3 times per day) [44]. In case of penicillin allergy but no
type I allergy (quincke edema, anaphylaxis) we use
Cefepim (2 g i.v. 3 times per day). In type I penicillin al-
lergy we use a combination of ether Vancomycin or Dapto-
mycin in combination with Gentamicin or Ciprofloxacin.
We always tried to preserve Ciprofloxacin as the only oral
Pseudomonas active agent for ambulant long-term treat-
ment of our patients. As soon as available we change from
empiric to goal directed antimicrobial treatment according
to the microbiological test and resistogram results.
Conclusions
This epidemiologic study reveals a pathogen shift
from Gram-positive to Gram-negative strains with high
incidence of Pseudomonas and combined pathogen infec-
tions in type IIIC open fractures and major traumatic
amputations. Therefore, empiric antimicrobial treatment
must be adjusted. We recommend the use of Piperacillin/
Tazobactam in sub-/total traumatic amputations. As soon
as available antimicrobial treatment must change from
empiric to goal directed therapy according to the
microbiological test and resistogram results.
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